Duodenoscope-associated infection prevention: A call for evidence-based decision making

Abstract

Background Recent outbreaks of duodenoscope-associated multidrug-resistant organisms (MDROs) have brought attention to the infection risk from procedures performed with duodenoscopes. Prior to these MDRO outbreaks, procedures with duodenoscopes were considered safe and low risk for exogenous infection transmission, provided they were performed in strict accordance with manufacturer instructions for use and multisociety reprocessing guidelines. The attention and efforts of the scientific community, regulatory agencies, and the device industry have deepened our understanding of factors responsible for suboptimal outcomes. These include instrument design, reprocessing practices, and surveillance strategies for detecting patient and instrument colonization. Various investigations have made it clear that current reprocessing methods fail to consistently deliver a pathogen-free instrument. The magnitude of infection transmission has been underreported due to several factors. These include the types of organisms responsible for infection, clinical signs presenting in sites distant from ERCP inoculation, and long latency from the time of acquisition to infection. Healthcare providers remain hampered by the ill-defined infectious risk innate to the current instrument design, contradictory information and guidance, and limited evidence-based interventions or reprocessing modifications that reduce risk. Therefore, the objectives of this narrative review included identifying outbreaks described in the peer-reviewed literature and comparing the findings with infections reported elsewhere. Search strategies included accessing peer-reviewed articles, governmental databases, abstracts for scientific conferences, and media reports describing outbreaks. This review summarizes current knowledge, highlights gaps in traditional sources of evidence, and explores opportunities to improve our understanding of actual risk and evidence-based approaches to mitigate risk.

Publication History

Received: 21 May 2020

Accepted: 30 July 2020

Article published online:
17 November 2020

• References

• 1 Kimmery MB, Burnett DA, Carr-Locke DL. et al. ASGE Technology Assessment position paper: transmission of infection by gastrointestinal endoscopy. Gastrointest Endosc 1993; 39: 885-888
• 2 Rutala WA, Weber DJ. Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008. Department of Health and Human Services; 2008
• 3 ASGE Standards of Practice Committee. Banerjee S, Shen B. et al. Infection control during GI endoscopy. Gastrointest Endosc 2008; 67: 781-790
• 4 Petersen BT, Chennat J, Cohen J. et al. Multisociety guideline on reprocessing flexible GI endoscopes: 2011. Infect Cont Hosp Epidemiol 2011; 32: 527-537
• 5 Society of Gastroenterology Nurses and Associates. SGNA Standards: standards of infection control in reprocessing of flexible gastrointestinal endoscopes. Gastroenterol Nurs 2010; 33: 70-80
• 6 Spach DH, Silverstein FE, Stamm WE. Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann Intern Med 1993; 118: 117-128
• 7 Ofstead CL, Dirlam Langlay AM, Mueller NJ. et al. Re-evaluating endoscopy-associated infection risk estimates and their implications. Am J Infect Control 2013; 41: 734-736
• 8 Grein JD, Murthy RK. New developments in the prevention of gastrointestinal scope-related infections. Infect Dis Clin N Am 2018; DOI: 10.1016/j.idc.2018.06.008.
• 9 Muscarella LF. Use of ethylene-oxide gas sterilisation to terminate multidrug-resistant bacterial outbreaks linked to duodenoscopes. BMJ Open Gastroenterol 2019; 6: e000282
• 10 Calderwood AH, Day LW, Muthusamy VR. et al. ASGE guideline for infection control during GI endoscopy. Gastrointest Endosc 2018; 87: 1167-1179
• 11 Bails J. Candor praised in scope problems. Pittsburgh Tribune-Review. 2005 Available from: http://www.pittsburghlive.com/x/pittsburghtrib/trib/tribeast/s_319469.html
• 12 Young M. No increase in infections despite sterilization problem, officials say. Vancouver Sun. 2010 Available from: http://www.vancouversun.com/increase+infections+despite+sterilization+problem+officials/3955640/story.html
• 13 Hill C. Error in manufacturer's disinfecting instructions prompts patient notification. Minneapolis: Hennepin County Medical Center; 2010
• 14 Thornhill G, David M. Endoscope-associated infections: a microbiologist's perspective on current technologies. Tech Gastrointest Endosc 2019; DOI: 10.1016/j.tgie.2019.150625.
• 15 Saleh N. Post-endoscopic infection rates are higher than '1 in a million'. MDLinx ed, In the News. 2018 Available from: https://www.mdlinx.com/gastroenterology/article/2029
• 16 Food and Drug Administration. Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning: FDA Safety Communication. 2015 Available from: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm434871.htm
• 17 Wang P, Xu T, Ngamruengphong S. et al. Rates of infection after colonoscopy and osophagogastroduodenoscopy in ambulatory surgery centres in the USA. Gut 2018; 0: 1-11
• 18 Council for International Organizations of Medical Science. Definitions. Available from: https://www.who.int/medicines/areas/quality_safety/safety_efficacy/trainingcourses/definitions.pdf
• 19 Loor MM, Morancy JD, Glover JK. et al. Single-setting endoscopic retrograde cholangiopancreatography (ERCP) and cholecystectomy improve the rate of surgical site infection. Surg Endosc 2017; 31: 5135-5142
• 20 Ofstead CL, Doyle EM, Eiland JE. et al. Practical toolkit for monitoring endoscope reprocessing effectiveness: identification of viable bacteria on gastroscopes, colonoscopes, and bronchoscopes. Am J Infect Control 2016; 44: 815-819
• 21 England D, Houseman J, Horn L. et al. Documented transmission of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae from patient to gastroscope. Infect Control Hosp Epidemiol 2016; 37: 493-494
• 22 Carbonne A, Thiolet JM, Fournier S. et al. Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009. Euro Surveill 2010; 15: 1-6
• 23 Kim S, Russell D, Mohamadnejad M. et al. Risk factors associated with the transmission of carbapenem-resistant Enterobacteriaceae via contaminated duodenoscopes. Gastrointest Endosc 2016; 83: 1121-1129
• 24 Rauwers AW, Voor In't Holt AF, Buijs JG. et al. High prevalence rate of digestive tract bacteria in duodenoscopes: a nationwide study. Gut 2018; DOI: 10.1136/gutjnl-2017-315082.
• 25 Epstein L, Hunter JC, Arwady MA. et al. New Delhi metallo-beta-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA 2014; 312: 1447-1455
• 26 Frias M, Tsai V, Moulton-Meissner H. et al. Notes from the field: New Delhi-metallo-beta-lactamase-producing Escherichia coli associated with endoscopic retrograde cholangiopancreatography - Illinois, 2013. Morb Mortal Wkly Rep 2014; 62: 1051-1051
• 27 Food and Drug Administration. Olympus Medical Systems Corp. Evis Exera Duodenovideoscope. MAUDE Adverse Event Report 8379810. Silver Spring, MD: 2019
• 28 Food and Drug Administration. Olympus Medical Systems Corp. Evis Exera Duodenovideoscope. MAUDE Adverse Event Report 8204386. Silver Spring, MD: 2019
• 29 Chandrasekhara V, Khashab MA, Muthusamy VR. et al. Adverse events associated with ERCP. Gastrointest Endosc 2017; 85: 32-47
• 30 Thosani N, Zubarik RS, Kochar R. et al. Prospective evaluation of bacteremia rates and infectious complications among patients undergoing single-operator choledochoscopy during ERCP. Endoscopy 2016; 48: 424-431
• 31 Bai Y, Gao F, Gao J. et al. Prophylactic antibiotics cannot prevent endoscopic retrograde cholangiopancreatography-induced cholangitis: a meta-analysis. Pancreas 2009; 38: 126-130
• 32 Khashab MA, Chithadi KV, Acosta RD. et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 2015; 81: 81-89
• 33 Kullman E, Borch K, Lindström E. et al. Bacteremia following diagnostic and therapeutic ERCP. Gastrointest Endosc 1992; 38: 444-449
• 34 Bartles RL, Leggett JE, Hove S. et al. A randomized trial of single versus double high-level disinfection of duodenoscopes and linear echoendoscopes using standard automated reprocessing. Gastrointest Endosc 2018; 88: 306-313
• 35 Rex DK, Sieber M, Lehman GA. et al. A double-reprocessing high-level disinfection protocol does not eliminate positive cultures from the elevators of duodenoscopes. Endoscopy 2017; 50: 588-596
• 36 Snyder GM, Wright SB, Smithey A. et al. Randomized comparison of 3 high-level disinfection and sterilization procedures for duodenoscopes. Gastroenterology 2017; 153: 1018-1025
• 37 Visrodia K, Hanada Y, Pennington KM. et al. Duodenoscope reprocessing surveillance with adenosine triphosphate testing and terminal cultures: a clinical pilot study. Gastrointest Endosc 2017; 86: 180-186
• 38 Gromski M, Sieber M, Sherman S. et al. Double high-level disinfection vs. sterilization for reprocessing of duodenoscopes used for ERCP: a prospective study. Am J Gastroenterol 2019; 114: S1
• 39 Verfaillie CJ, Bruno MJ, Voor in’t holt AF. et al. Withdrawal of a novel-design duodenoscope ends outbreak of a VIM-2-producing Pseudomonas aeruginosa . Endoscopy 2015; 47: 493-502
• 40 Alrabaa SF, Nguyen P, Sanderson R. et al. Early identification and control of carbapenemase-producing Klebsiella pneumoniae, originating from contaminated endoscopic equipment. Am J Infect Control 2013; 41: 562-564
• 41 Epstein L, Hunter J, Arwady A. Epi-Aid Trip Report: outbreak of New Delhi metallo-beta-lactamase-producing. E. coli at an acute care hospital, Chicago Region. Centers for Disease Control and Prevention. Atlanta, GA: Department of Health and Human Services; 2013
• 42 Ross AS, Baliga C, Verma P. et al. A quarantine process for the resolution of duodenoscope-associated transmission of multidrug-resistant Escherichia coli . Gastrointest Endosc 2015; 82: 477-483
• 43 Rauwers AW, Troelstra A, Fluit AC. et al. Independent root cause analysis of contributing factors, including dismantling of 2 duodenoscopes, to an outbreak of multidrug-resistant Klebsiella pneumoniae . Gastrointest Endosc 2019; DOI: 10.1016/j.gie.2019.05.016.
• 44 Aumeran C, Poincloux L, Souweine B. et al. Multidrug-resistant Klebsiella pneumoniae outbreak after endoscopic retrograde cholangiopancreatography. Endoscopy 2010; 42: 895-899
• 45 Food and Drug Administration. Supplemental measures to enhance duodenoscope reprocessing: FDA Safety Communication. 2015 Available from: https://www.fdanews.com/ext/resources/files/08-15/081015-duodenoscopes-fda.pdf?1520541508
• 46 Dylla B, Kohner P, Ihde S. et al. Comparison of two methods for culturing reprocessed duodenoscopes. Boston, MA: ASM Microbe; 2016
• 47 Ofstead CL, Heymann OL, Quick MR. et al. The effectiveness of sterilization for flexible ureteroscopes: a real-world study. Am J Infect Control 2017; 45: 888-895
• 48 Chapman CG, Siddiqui UD, Manzano M. et al. Risk of infection transmission in curvilinear array echoendoscopes: results of a prospective reprocessing and culture registry. Gastrointest Endosc 2017; 85: 390-397.e391
• 49 Saliou P, Le Bars H, Payan C. et al. Measures to improve microbial quality surveillance of gastrointestinal endoscopes. Endoscopy 2016; 48: 704-710
• 50 Legemate JD, Kamphuis GM, Freund JE. et al. Pre-use ureteroscope contamination after high-level disinfection: reprocessing effectiveness and the relation with cumulative ureteroscope use. J Urol 2019; DOI: 10.1097/ju.0000000000000108.
• 51 Ofstead CL, Wetzler HP, Eiland JE. et al. Assessing residual contamination and damage inside flexible endoscopes over time. Am J Infect Control 2016; 44: 1675-1677
• 52 Ofstead CL, Quick MR, Wetzler HP. et al. Effectiveness of reprocessing for flexible bronchoscopes and endobronchial ultrasound bronchoscopes. Chest 2018; 154: 1024-1034
• 53 Ofstead CL, Wetzler HP, Heymann OL. et al. Longitudinal assessment of reprocessing effectiveness for colonoscopes and gastroscopes: results of visual inspections, biochemical markers, and microbial cultures. Am J Infect Control 2017; 45: e26-e33
• 54 Ofstead CL, Wetzler HP, Doyle EM. et al. Persistent contamination on colonoscopes and gastroscopes detected by biologic cultures and rapid indicators despite reprocessing performed in accordance with guidelines. Am J Infect Control 2015; 43: 794-801
• 55 Ofstead CL, Heymann OL, Quick MR. et al. Residual moisture and waterborne pathogens inside flexible endoscopes: evidence from a multisite study of endoscope drying effectiveness. Am J Infect Control 2018; 46: 689-696
• 56 Ofstead CL, Wetzler HP, Snyder AK. et al. Endoscope reprocessing methods: a prospective study on the impact of human factors and automation. Gastroenterol Nurs 2010; 33: 304-311
• 57 Food and Drug Administration. The FDA provides interim results of duodenoscope reprocessing studies conducted in real-world settings: FDA Safety Communication. 2018 Available from: https://www.fda.gov/medical-devices/safety-communications/fda-provides-interim-results-duodenoscope-reprocessing-studies-conducted-real-world-settings-fda
• 58 The Joint Commission. 4-1-1 on survey enhancements: new scoring revisions of IC.02.02.01. 2018 Available from: https://www.jointcommission.org/issues/article.aspx?Article=G/xUdh/VKujxJ12FY7q2i0ousSBZsyucrGSdk+Hj1O8=
• 59 Armellino D, Cifu K, Wallace M. et al. Implementation of remote video auditing with feedback and compliance for manual-cleaning protocols of endoscopic retrograde cholangiopancreatography endoscopes. Am J Infect Control 2018; 46: 594-596
• 60 Thaker AM, Kim S, Sedarat A. et al. Inspection of endoscope instrument channels after reprocessing using a prototype borescope. Gastrointest Endosc 2018; 88: 612-619
• 61 Barakat MT, Girotra M, Huang RJ. et al. Scoping the scope: endoscopic evaluation of endoscope working channels with a new high-resolution inspection endoscope (with video). Gastrointest Endosc 2018; 88: 601-611
• 62 The Joint Commission. The 5 most challenging requirements for first half of 2018. 2018 Available from: https://www.jointcommission.org/sitecore/media-library/tjc/newsletters/jc_online_sept_192pdf/
• 63 Kumarage J, Khonyongwa K, Khan A. et al. Transmission of MDR Pseudomonas aeruginosa between two flexible ureteroscopes and an outbreak of urinary tract infection: the fragility of endoscope decontamination. J Hosp Infect 2019; 102: 89-94
• 64 Food and Drug Administration. Medivators Advantage Plus Automated Endoscope Reprocessor. MAUDE Adverse Event Report 8287300. Silver Spring, MD: 2019
• 65 Food and Drug Administration. Medivators DSD-201 Automated Endoscope Reprocessor. MAUDE Adverse Event Report 8524712. Silver Spring, MD: 2019
• 66 Barakat MT, Huang RJ, Banerjee S. Comparison of automated and manual drying in the elimination of residual endoscope working channel fluid after reprocessing (with video). Gastrointest Endosc 2019; 89: 124-132e122
• 67 Galdys AL, Marsh JW, Delgado E. et al. Bronchoscope-associated clusters of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Klebsiella pneumoniae . Infect Control Hosp Epidemiol 2019; 40: 40-46
• 68 Foshay K. Medical scope now tied to Wisconsin superbug outbreak. 2015 Available from: http://america.aljazeera.com/watch/shows/america-tonight/articles/2015/3/4/Medical-scope-tied-to-Wisconsin-superbug-outbreak.html
• 69 Food and Drug Administration. Olympus Medical System Corporation Evis Exera II Duodenovideoscope. MAUDE Adverse Event Report 3608977. Silver Spring, MD: 2014
• 70 Food and Drug Administration. Olympus Medical System Corporation Evis Exera II Duodenovideoscope. MAUDE Adverse Event Report 3608996. Silver Spring, MD: 2014
• 71 Food and Drug Administration. Olympus Medical System Corporation Evis Exera II Duodenovideoscope. MAUDE Adverse Event Report 3608981. Silver Spring, MD: 2014
• 72 Smith ZL, Oh YS, Saeian K. et al. Transmission of carbapenem-resistant Enterobacteriaceae during ERCP: time to revisit the current reprocessing guidelines. Gastrointest Endosc 2015; 81: 1041-1045
• 73 Humphries RM, Yang S, Kim S. et al. Duodenoscope-related outbreak of a carbapenem-resistant Klebsiella pneumoniae identified using advanced molecular diagnostics. Clin Infect Dis 2017; 65: 1159-1166
• 74 Jousset AB, Bonnin RA, Rosinski-Chupin I. et al. 4.5 years within-patient evolution of a colistin resistant KPC-producing Klebsiella pneumoniae ST258. Clin Infect Dis 2018; DOI: 10.1093/cid/ciy293.
• 75 Food and Drug Administration. FDA orders duodenoscope manufacturers to conduct postmarket surveillance studies in health care facilities. 2015 Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm465639.htm
• 76 Food and Drug Administration. Statement from Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on continued efforts to assess duodenoscope contamination risk. 2019 Available from: https://www.fda.gov/news-events/press-announcements/statement-jeff-shuren-md-jd-director-center-devices-and-radiological-health-updated-safety
• 77 Food and Drug Administration. Olympus 522 Post Market Surveillance Studies--Sampling and culturing study. Department of Health and Human Services. 2020 Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pss.cfm?t_id=354&c_id=3726
• 78 Food and Drug Administration. Pentax 522 Post Market Surveillance Studies--Sampling and culturing study. Department of Health and Human Services. 2020 Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pss.cfm?t_id=355&c_id=3727
• 79 Food and Drug Administration. Fujifilm 522 Postmarket Surviellance Studies--Sampling and culturing study. Department of Health & Human Services. 2018 Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pss.cfm?t_id=353&c_id=3725
• 80 Food and Drug Administration. Fujifilm 522 Post Market Surveillance Studies--Sampling and culturing study. Department of Health and Human Services. 2020 Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pss.cfm?t_id=353&c_id=3725
• 81 Alfa MJ, Singh H. Impact of wet storage and other factors on biofilm formation and contamination of patient-ready endoscopes: a narrative review. Gastrointest Endosc 2019; DOI: 10.1016/j.gie.2019.08.043.
• 82 Food and Drug Administration. Olympus Medical Systems Corp. Evis Exera II Duodenovideoscope. MAUDE Adverse Event Report 8030512. Silver Spring, MD: 2018
• 83 Food and Drug Administration. Olympus Medical Systems Corp. Evis Exera II Duodenovideoscope. MAUDE Adverse Event Report 8034924. Silver Spring, MD: 2018
• 84 Food and Drug Administration. Olympus Medical Systems Corp. Evis Exera II Duodenovideoscope. MAUDE Adverse Event Report 8365270. Silver Spring, MD: 2019
• 85 Centers for Disease Control and Prevention. Interim protocol for healthcare facilities regarding surveillance for bacterial contamination of duodenoscopes after reprocessing. Department of Health & Human Services; 2015
• 86 Taylor A, Jones D, Everts R. et al. Infection Control in Endoscopy. 3rd ed. Gastroenterological Society of Australia Gastroenterological Nurses College of Australia; 2011
• 87 Beilenhoff U, Neumann CS, Rey JF. et al. ESGE-ESGENA guideline for quality assurance in reprocessing: microbiological surveillance testing in endoscopy. Endoscopy 2007; 39: 175-181
• 88 Public Health Agency of Canada. Infection prevention and control guideline for flexible gastrointestinal endoscopy and flexible bronchoscopy. Infection Prevention and Control Program. 2010
• 89 Minnesota Department of Health. Hennepin County Medical Center investigative report and CMS-2567. Office of Health Facility Complaints; 2010
• 90 Ray MJ, Lin MY, Tang AS. et al. Regional spread of an outbreak of carbapenem-resistant Enterobacteriaceae (CRE) through an ego network of healthcare facilities. Clin Infect Dis 2018; DOI: 10.1093/cid/ciy084.
• 91 World Health Organization. Global action plan on antimicrobial resistance. Geneva, Switzerland: 2015
• 92 Centers for Disease Control and Prevention. Core elements of antibiotic stewardship. Antibiotic Prescribing and Use in Hospitals and Long-Term Care. 2019 Available from: https://www.cdc.gov/antibiotic-use/core-elements/index.html
• 93 Masadeh M, Chandra S, Livorsi D. et al. Evaluation of biliary bacterial resistance in patients with frequent biliary instrumentation, one size does not fit all. Dig Dis Sci 2018; DOI: 10.1007/s10620-018-5263-5.
• 94 Ishigaki T, Sasaki T, Serikawa M. et al. Evaluation of antibiotic use to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis and cholangitis. Hepatogastroenterology 2015; 62: 417-424
• 95 Du M, Suo J, Liu B. et al. Post-ERCP infection and its epidemiological and clinical characteristics in a large Chinese tertiary hospital: a 4-year surveillance study. Antimicrob Resist Infect Control 2017; 6: 131
• 96 Wendorf KA, Kay M, Baliga C. et al. Endoscopic retrograde cholangiopancreatography-associated AmpC Escherichia coli outbreak. Infect Control Hosp Epidemiol 2015; 36: 634-642
• 97 Bourigault C, Le Gallou F, Bodet N. et al. Duodenoscopy: an amplifier of cross-transmission during a carbapenemase-producing Enterobacteriaceae outbreak in a gastroenterology pathway. J Hosp Infect 2018; DOI: 10.1016/j.jhin.2018.04.015.
• 98 Shenoy ES, Pierce VM, Walters MS. et al. Transmission of mobile colistin resistance (mcr-1) by duodenoscope. Clin Infect Dis 2018; 68: 1327-1334
• 99 Robertson P, Smith A, Anderson M. et al. Transmission of Salmonella enteritidis after endoscopic retrograde cholangiopancreatography because of inadequate endoscope decontamination. Am J Infect Control 2017; 45: 440-442
• 100 Kola A, Piening B, Pape UF. et al. An outbreak of carbapenem-resistant OXA-48 - producing Klebsiella pneumonia associated to duodenoscopy. Antimicrob Resist Infect Control 2015; 4: 8
• 101 Marsh JW, Krauland MG, Nelson JS. et al. Genomic epidemiology of an endoscope-associated outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae . PloS One 2015; 10: e0144310
• 102 Qiu L, Zhou Z, Liu Q. et al. Investigating the failure of repeated standard cleaning and disinfection of a Pseudomonas aeruginosa-infected pancreatic and biliary endoscope. Am J Infect Control 2015; 43: e43-46
• 103 Sanderson R, Braithwaite L, Ball L. et al. An outbreak of carbapenem-resistant Klebsiella pneumoniae infections associated with endoscopic retrograde cholangiopancreatography (ERCP) procedures at a hospital. Am J Infect Control 2010; 38: e141
• 104 Sanderson R. An outbreak of carbapenem-resistant Klebsiella pneumoniae infections associated with endoscopic retrograde cholangiopancreatography (ERCP) procedures at a hospital. APIC. New Orleans, LA: 2010
• 105 Centers for Medicare and Medicaid Services. Advocate Lutheran General Hospital - CMS-2567 Statement of Deficiencies and Plan of Correction. Department of Health and Human Services; 2014
• 106 Yang S, Hemarajata P, Hindler J. et al. Evolution and transmission of carbapenem-resistant Klebsiella pneumoniae expressing the blaOXA-232 gene during an institutional outbreak associated with endoscopic retrograde cholangiopancreatography. Clin Infect Dis 2017; 64: 894-901
• 107 University of California – Los Angeles. UCLA statement on notification of patients regarding endoscopic procedures. 2015 Available from: https://www.uclahealth.org/body.cfm?id=1397&action=detail&ref=1216&fr=true
• 108 Rubin Z. Carbapenem resistant Klebsiella pneumoniae following endoscopic retrograde cholangiopancreatography at Ronald Reagan University Medical Center. FDA Gastroenterology-Urology Devices Panel. Washington, D.C: UCLA Health System; 2015
• 109 Centers for Medicare and Medicaid Services. Ronald Reagan UCLA Medical Center Statement of Deficiencies and Plan of Correction. 2015: 1-42
• 110 Hunter J, Epstein L. Epi-Aid Trip Report: cluster of plasmid-mediated AmpC-producing carbapenem-resistant Enterobacteriaceae (CRE) - Washington, 2014 (Epi-2014-043). Atlanta, GA: Centers for Disease Control and Prevention; 2014: 24
• 111 Food and Drug Administration. Olympus Medical System Corporation Olympus Duodenovideoscope. MAUDE Adverse Event Report 4077782. Silver Spring, MD: 2014
• 112 Food and Drug Administration. Olympus Medical System Corporation Olympus Duodenovideoscope. MAUDE Adverse Event Report 4083574. Silver Spring, MD: 2014
• 113 Centers for Medicare and Medicaid Services. Virginia Mason Medical Center - Case file. 2015
• 114 Food and Drug Administration. Olympus Medical Systems Corp. MAUDE Adverse Event Report 8177954. Silver Spring, MD: 2019
• 115 Food and Drug Administration. Olympus Medical Systems Corp. Evis Exera Duodenovideoscope. MAUDE Adverse Event Report 8820754. Silver Spring, MD: 2019
• 116 Food and Drug Administration. Olympus Medical Systems Corp. Evis Lucera Duodenovideoscope. MAUDE Adverse Event Report 8538532. Silver Spring, MD: 2019
• 117 Food and Drug Administration. Olympus Medical Systems Corp. Evis Exera II Duodenovideoscope. MAUDE Adverse Event Report 7027139. Silver Spring, MD: 2017
• 118 Food and Drug Administration. Olympus Medical Systems Corp. Evis Exera II Duodenovideoscope. MAUDE Adverse Event Report 8201861. Silver Spring, MD: 2018
• 119 Food and Drug Administration. Olympus Medical Systems Corp. Evis Exera II Duodenovideoscope. MAUDE Adverse Event Report 8201871. Silver Spring, MD: 2018
• 120 Food and Drug Administration. Pentax of America, Inc. Video Duodenoscope Duodenoscope and Accessories, Flexible/Rigid. MAUDE Adverse Event Report 7548459. Silver Spring, MD: 2018
• 121 Food and Drug Administration. Olympus Medical Systems Corp. Evis Exera II Duodenovideoscope. MAUDE Adverse Event Report 8730284. Silver Spring, MD: 2019
• 122 Food and Drug Administration. Olympus Medical Systems Corp. Evis Exera II Duodenovideoscope. MAUDE Adverse Event Report 8825520. Silver Spring, MD: 2019
• 123 Food and Drug Administration. Olympus Medical Systems Corp. Evis Exera Duodenovideoscope. MAUDE Adverse Event Report 8751568. Silver Spring, MD: 2019
• 124 Food and Drug Administration. Olympus Medical Systems Corp. Evis Exera II Duodenovideoscope. MAUDE Adverse Event Report 7791919. Silver Spring, MD: 2018
• 125 Food and Drug Administration. Olympus Medical Systems Corp. Evis Exera II Duodenovideoscope. MAUDE Adverse Event Report 7424492. Silver Spring, MD: 2018
• 126 Food and Drug Administration. Olympus 522 postmarket surveillance studies--Sampling and culturing study. Department of Health & Human Services; 2019 Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pss.cfm?t_id=354&c_id=3726
• 127 Food and Drug Administration. Pentax 522 Post Market Surveillance Studies--Sampling and culturing study. Department of Health & Human Services; 2018 Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pss.cfm?t_id=355&c_id=3727